- A total of 80 adoptive cell relevant abstracts which can be linked to a therapy or trial have been identified from the meeting and we have taken the time to present a summary of these in this post-conference report. The abstract number will be presented along with the respective drug or trial page on Beacon and a summary of these abstracts. The full list of these abstracts can be found here.
- Included is also additional analysis and comparison of the abstracts relevant to the Beacon advanced therapies datasets.
- We hope that you find this post-conference report useful and insightful.
Find out more
Speak with our Team
Our dedicated team can help you with questions by showing you how this insight and data is collated on Beacon.
About Beacon Targeted Therapies
We are a clinical trial and pipeline database solution, designed in partnership with pharmaceutical professionals. We track targeted therapies to provide accurate, in-depth and real-time information in the rapidly evolving landscape of drug development.
Learn more about how our clinical trials and drug database solutions can be tailored to your research requirements
